Research programme: sulfonamide derivatives - Telik

Drug Profile

Research programme: sulfonamide derivatives - Telik

Alternative Names: Carboxylesterase inhibitors

Latest Information Update: 20 Dec 2007

Price : $50

At a glance

  • Originator Telik
  • Class Sulfonamides
  • Mechanism of Action Enzyme inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 20 Apr 2004 Preclinical trials in Cancer (Prevention)/Chemoprevention in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top